Literature DB >> 34254287

Blinatumomab for paediatric mixed phenotype acute leukaemia.

Jack Bartram1,2, Milena Balasch-Carulla1, Shashank Bhojaraja1, Stuart Adams2, Danny Cheng1, Sarah Inglott2, Nimish Kulkarni1, Arunthethy Mahendrayogam1, Olya O'Connor1, Vesna Pavasovic1, Ajay Vora1.   

Abstract

Entities:  

Keywords:  immunotherapy; leukaemia; leukaemia therapy; mixed phenotype acute leukaemia; paediatric haematology

Mesh：

Substances：

Year:  2021        PMID： 34254287     DOI： 10.1111/bjh.17707

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.

Authors:  Alexandra Semchenkova; Ekaterina Mikhailova; Alexander Komkov; Marina Gaskova; Ruslan Abasov; Evgenii Matveev; Marat Kazanov; Ilgar Mamedov; Anna Shmitko; Vera Belova; Anna Miroshnichenkova; Olga Illarionova; Yulia Olshanskaya; Grigory Tsaur; Tatiana Verzhbitskaya; Natalia Ponomareva; Gleb Bronin; Konstantin Kondratchik; Larisa Fechina; Yulia Diakonova; Liudmila Vavilova; Natalia Myakova; Galina Novichkova; Alexey Maschan; Michael Maschan; Elena Zerkalenkova; Alexander Popov
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.